Limited to 1,000 words, we address some serious technical mistakes and factual errors, as well as the misleading quotations in the section of Olshansky’s and Carnes’ article that attacks some of our joint research.

Keywords:
Mortality, Life expectancy, Forecasting
1.
Olshansky SJ, Carnes BA: Zeno’s paradox of immortality. Gerontology, 2013;59:85–92.
2.
Vaupel JW: Biodemography of human aging. Nature 2010;464:536–542.
3.
Christensen K, Doblhammer G, Rau R, Vaupel JW: Ageing populations: the challenges ahead. Lancet 2009;374:1196–1208.
4.
Oeppen J, Vaupel JW: Broken limits to life expectancy. Science 2002;296:1029–1031.
5.
University of California, Berkeley (USA) and Max Planck Institute for Demographic Research, Rostock (Germany). Human Mortality Database. http://www.mortality.org (accessed May 4, 2012).
6.
Shkolnikov VM, Jdanov DA, Andreev EM, Vaupel JW: Steep increase in best-practice cohort life expectancy. Popul Dev Rev 2011;37:419–434.
7.
Missov TI, Lenart A: Linking period and cohort life-expectancy linear increases in Gompertz proportional hazards models. Demogr Res 2011;24:455–468.
8.
Bongaarts J: Long-range trends in adult mortality: models and projection methods. Demography 2005;42:23–49.
9.
Crimmins EM, Preston SH, Cohen B (eds): Explaining Divergent Levels of Longevity in High-Income Countries. Washington, The National Academies Press, 2011.
10.
Crimmins EM, Preston SH, Cohen B (eds): International Differences in Mortality at Older Ages. Dimensions and Sources. Washington, The National Academies Press, 2010.
11.
Kannisto V, Lauritsen J, Thatcher AR, Vaupel JW: Reductions in mortality at advanced ages: several decades of evidence from 27 countries. Popul Dev Rev 1994;20:793–810.
12.
Wilmoth JR: In search of limits; in Wachter KW, Finch CE (eds): Between Zeus and the Salmon: The Biodemography of Longevity. Washington, The National Academies Press, 1997, pp 38–55.
13.
Rau R, Jasilionis D, Soroko EL, Vaupel JW: Continued reductions in mortality at advanced ages. Popul Dev Rev 2008;34:747–768.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.